PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 128 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,486 | -25.5% | 2,086 | 0.0% | 0.00% | – |
Q2 2023 | $7,363 | -93.4% | 2,086 | -94.6% | 0.00% | – |
Q1 2022 | $112,000 | -5.1% | 38,775 | +0.0% | 0.00% | – |
Q4 2021 | $118,000 | -57.6% | 38,771 | -2.1% | 0.00% | – |
Q3 2021 | $278,000 | -22.3% | 39,609 | +1.5% | 0.00% | – |
Q2 2021 | $358,000 | -11.2% | 39,041 | -5.9% | 0.00% | -100.0% |
Q1 2021 | $403,000 | -13.1% | 41,489 | -8.4% | 0.00% | 0.0% |
Q4 2020 | $464,000 | +9.4% | 45,269 | +7.8% | 0.00% | 0.0% |
Q3 2020 | $424,000 | -17.2% | 42,009 | -14.4% | 0.00% | 0.0% |
Q2 2020 | $512,000 | +45.0% | 49,071 | +17.5% | 0.00% | 0.0% |
Q1 2020 | $353,000 | -2.5% | 41,771 | +0.8% | 0.00% | 0.0% |
Q4 2019 | $362,000 | -17.0% | 41,422 | +2.2% | 0.00% | 0.0% |
Q3 2019 | $436,000 | -15.8% | 40,529 | -0.6% | 0.00% | 0.0% |
Q2 2019 | $518,000 | -65.5% | 40,771 | +5.3% | 0.00% | -66.7% |
Q1 2019 | $1,501,000 | +89.5% | 38,705 | -0.6% | 0.00% | +50.0% |
Q4 2018 | $792,000 | -34.9% | 38,938 | +46.6% | 0.00% | 0.0% |
Q3 2018 | $1,217,000 | -27.3% | 26,553 | -6.2% | 0.00% | -33.3% |
Q2 2018 | $1,674,000 | -12.6% | 28,294 | +0.5% | 0.00% | -25.0% |
Q1 2018 | $1,916,000 | -33.3% | 28,161 | -3.1% | 0.00% | -33.3% |
Q4 2017 | $2,872,000 | -31.1% | 29,055 | -16.5% | 0.01% | -33.3% |
Q3 2017 | $4,167,000 | +41.4% | 34,794 | +3.1% | 0.01% | +28.6% |
Q2 2017 | $2,948,000 | +136.8% | 33,733 | +0.8% | 0.01% | +133.3% |
Q1 2017 | $1,245,000 | +26.7% | 33,462 | +4.5% | 0.00% | +50.0% |
Q4 2016 | $983,000 | -46.0% | 32,033 | +18.0% | 0.00% | -60.0% |
Q3 2016 | $1,821,000 | +123.4% | 27,152 | -0.8% | 0.01% | +150.0% |
Q2 2016 | $815,000 | +18.3% | 27,358 | +16.7% | 0.00% | 0.0% |
Q1 2016 | $689,000 | -63.8% | 23,451 | -3.4% | 0.00% | -66.7% |
Q4 2015 | $1,904,000 | +2.9% | 24,283 | -1.1% | 0.01% | 0.0% |
Q3 2015 | $1,851,000 | -36.7% | 24,557 | -2.0% | 0.01% | -33.3% |
Q2 2015 | $2,925,000 | -51.0% | 25,054 | -0.9% | 0.01% | -47.1% |
Q1 2015 | $5,971,000 | +45.9% | 25,289 | +17.0% | 0.02% | +41.7% |
Q4 2014 | $4,093,000 | -22.2% | 21,623 | -1.9% | 0.01% | -25.0% |
Q3 2014 | $5,260,000 | +268.9% | 22,048 | +2.1% | 0.02% | +300.0% |
Q2 2014 | $1,426,000 | -35.0% | 21,604 | +2.5% | 0.00% | -42.9% |
Q1 2014 | $2,194,000 | -3.3% | 21,067 | -3.9% | 0.01% | 0.0% |
Q4 2013 | $2,270,000 | +99.8% | 21,924 | +3.5% | 0.01% | +75.0% |
Q3 2013 | $1,136,000 | +32.2% | 21,174 | +9.4% | 0.00% | +33.3% |
Q2 2013 | $859,000 | – | 19,350 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
State of Wyoming | 20,732 | $59,000 | 0.04% |
Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |